Huikang Medical

Shenzhen Huikang Company is a * supplier of medical treatment equipment. Since its establishment, Huikang Company has been dedicated to the research, development and manufacturing of high-tech medical equipment. Its products cover the extracorporeal shock wave lithotripsy (ESWL) treatment series, extracorporeal shock wave orthopedic treatment devices and pain treatment series (ESWT), urological diagnosis and treatment bed series (UROT), medical image archiving and transmission series (PACS), and high-intensity focused ultrasound tumor treatment series (HIFU). The company's product sales and market share have ranked *** in the domestic medical lithotripter industry for many consecutive years, making it an * enterprise in the industry. It is a permanent member of the APEC Business Advisory Council and has participated in Belt and Road business activities multiple times. The company's products have been sold to more than 40 countries and regions, with cumulative domestic and international sales revenue exceeding 100 million yuan. The global cumulative installation of extracorporeal shock wave lithotripters exceeds 5,000 units, making it a manufacturer with the *** installation volume in China and ranking among the top globally. Huikang Company is among the first batch of *** high-tech enterprises recognized by the Chinese government, possessing 70 patents and software copyrights, including 16 invention patents, 17 utility model patents, 1 design patent, 31 software copyrights, and 5 domestic trademarks. The company masters core technologies for various medical and civilian health care shock wave sources, and has deep technical expertise in core technologies such as shock wave and ultrasonic high-energy focusing physical characteristics, energy detection, medical transducers, and main control platforms. It has three major technology platforms at the * level of the industry: medical shock wave technology platform, high-energy ultrasound technology platform, and opto-electromechanical platform. Through these platforms, it has carried out diversified product expansion, forming industrialized production of series products such as extracorporeal shock wave lithotripters, shock wave treatment machines, shock wave *** dysfunction treatment devices, shock wave prostate treatment devices, urological diagnosis and treatment beds, and stone removal beds. At the same time, it has new product reserves for treatment equipment such as low-energy shock wave coronary heart disease treatment devices, in vivo shock wave heart valve repair, and cardiovascular calcification repair treatment devices. The company is at the * level in low-energy lithotripsy technology, electromagnetic shock wave technology, shock wave pain treatment technology, and medical micro-energy repair technology.